Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.BMS plans to sell Celgene’s psoriasis drug Otezla
Image: Bristol-Myers Squibb is planning to sell Celgene’s psoriasis drug Otezla to complete the acquisition. Photo: courtesy of Sue Adair/Wikimedia Commons.
Image: Bristol-Myers Squibb is planning to sell Celgene’s psoriasis drug Otezla to complete the acquisition. Photo: courtesy of Sue Adair/Wikimedia Commons.